TP53 and B-cell chronic lymphocytic leukemia: Indeed, deletions and mutations of TP53 and ATM have been reported in monoclonal B-cell lymphocytosis (MBL) and early-stage CLL, albeit at much lower frequencies than in patients with more clinically advanced disease [33,34].